IRF8-dependent molecular complexes control the Th9 transcriptional program

Abstract : Interferon regulatory factors (IRF) have critical functions in lymphoid development and in immune response regulation. Although many studies have described the function of IRF4 in CD4+ T cells, few have focused on the IRF4 homologue, IRF8. Here, we show that IRF8 is required for Th9 differentiation in vitro and in vivo. IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription. By contrast, IRF8 deficiency promotes the expression of other genes such as Il4, as IRF8 dimerises with the transcriptional repressor ETV6 and inhibits Il4 expression. In vivo, IRF8 is essential for the anti-tumour effects of Th9 cells in mouse melanoma models. Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.
Type de document :
Article dans une revue
Domaine :
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01682219
Contributeur : Lnc - Université de Bourgogne <>
Soumis le : vendredi 12 janvier 2018 - 10:18:52
Dernière modification le : jeudi 7 février 2019 - 15:26:32

Lien texte intégral

Identifiants

Citation

Etienne Humblin, Marion Thibaudin, Fanny Chalmin, Valentin Derangere, Emeric Limagne, et al.. IRF8-dependent molecular complexes control the Th9 transcriptional program. Nature Communications, Nature Publishing Group, 2017, 8 (1), pp.2085. ⟨https://www.nature.com/articles/s41467-017-01070-w⟩. ⟨10.1038/s41467-017-01070-w⟩. ⟨hal-01682219⟩

Partager

Métriques

Consultations de la notice

114